Drug treatment
A Predictive Risk Model for Nonfatal Opioid Overdose in a Statewide Population of Buprenorphine Patients.
In Focus: Drug Courts
A Person-centered Approach to Risk and Need Classification in Drug Court
Best Practices for Successful Reentry for People Who Have Opioid Addictions
Substance Abuse Treatment Centers and Local Crime.
Concomitant Use of Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder and Benzodiazepines: Using the Prescription Behavior Surveillance System
Influence of Organizational Characteristics on Success in Implementing Process Improvement Goals in Correctional Treatment Settings Journal of Behavioral Health Services & Research
Office of Justice Programs (OJP) / Centers for Disease Control and Prevention (CDC) Federal Medicolegal Death Investigation Interagency Working Group (MDI-IWG) Resource Page
The Department of Justice’s (DOJ) Office of Justice Programs (OJP) and the U.S. Health and Human Services’ (HHS) Center for Disease Control and Prevention (CDC) established this Federal Medicolegal Death Investigation (MDI) Interagency Working Group (MDI-IWG) to coordinate Federal initiatives to strengthen MDI systems and support death investigation services practiced by medical examiner and coroner offices (MECs) across the United States. The MDI-IWG commenced in...